Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Mineralys Therapeutics, Inc.

NASDAQ: MLYS · Life Sciences · 6 alerts · CIK 1933414

Share price
$14.53Close, Nov 16
Market cap
$1.29B
Shares outstanding
88.56MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Mineralys Therapeutics, Inc. filings on SEC EDGAR ↗

5:53 PM ET Form 4
Insider Selling

Mineralys Therapeutics CEO Jon Congleton Sells $1.91M of Stock

Jon Congleton, CEO, sold 75,000 shares of Mineralys Therapeutics, Inc. at $25.46 a share, worth $1.91M in total on Sep 30, 2026. Shares held after the trade: 528,621 (-12.4%).

Value
$1.91M
Shares
75,000
Price
$25.46
Role
CEO
Holding change
-12.4%
Trade date
Sep 30, 2026
9:50 PM ET Form 4
Insider Selling

Mineralys Therapeutics Insider Brian Taylor Slingsby Sells $3.01M of Stock

Brian Taylor Slingsby sold 104,320 shares of Mineralys Therapeutics, Inc. at $28.81 a share, worth $3.01M in total on Sep 22, 2026. Shares held after the trade: 7,805,718 (-1.3%).

Value
$3.01M
Shares
104,320
Price
$28.81
Holding change
-1.3%
Trade date
Sep 22, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.